Země: Spojené státy
Jazyk: angličtina
Zdroj: NLM (National Library of Medicine)
Epinephrine (UNII: YKH834O4BH) (Epinephrine - UNII:YKH834O4BH)
International Medication Systems, Limited
Epinephrine
Epinephrine 0.1 mg in 1 mL
INTRAVENOUS
PRESCRIPTION DRUG
EPINEPHRINE Epinephrine’s cardiac effects may be of use in the treatment and prophylaxis of cardiac arrest due to various causes in the absence of ventricular fibrillation and attacks of transitory atrioventricular (AV) heart block with syncopal seizures (Stokes-Adams syndrome), but it is not used in cardiac failure or in hemorrhagic, traumatic or in cardiogenic shock. Epinephrine may be used to stimulate the heart in syncope due to complete heart block or carotid sinus hypersensitivity. Epinephrine is also used for resuscitation in cardiac arrest following anesthetic accidents. In cardiopulmonary resuscitation, intracardiac puncture and intramyocardial injection of epinephrine may be effective when external cardiac compression and attempts to restore the circulation by electrical defibillation or use of a pacemaker fail. Epinephrine is seldom used as a vasopressor except in the treatment of anaphylactic shock and under certain conditions in insulin shock. Epinephrine should not be used in the presence of car
EPINEPHRINE INJECTION, USP, 0.1 mg/ mL In unit-use packages containing a Luer-Jet™ Luer-Lock Prefilled Syringe Ten cartons per package. Syringe Assembly Directions: USE ASEPTIC TECHNIQUE Do not assemble until ready to use. *CAUTION: IMPROPER ENGAGING MAY CAUSE GLASS BREAKAGE AND SUBSEQUENT INJURY. Protect the solution from light, extreme heat and freezing. Store at controlled room temperature 15˚ to 30˚C (59˚ to 86˚F). NOTE: Do not use the injection if its color is pinkish or darker than slightly yellow or if it contains a precipitate. Rx Only
unapproved drug other
EPINEPHRINE - EPINEPHRINE INJECTION INTERNATIONAL MEDICATION SYSTEMS, LIMITED _Disclaimer: This drug has not been found by FDA to be safe and effective, and this_ _labeling has not been approved by FDA. For further information about unapproved_ _drugs, click here._ ---------- EPINEPHRINE INJECTION, USP AVAILABLE AS: EPINEPHRINE INJECTION, USP, 0.1 MG/ML FOR INTRACARDIAC OR INTRAVENOUS USE DESCRIPTION Epinephrine is the active principle of the adrenal medulla. Chemically described as (-)-3,4- Dihydroxy-α-[(methyl-amino) methyl] benzyl alcohol, it has the following structural formula: Epinephrine is a sterile aqueous solution of epinephrine prepared with the aid of hydrochloric acid. Each mL of the solution contains 0.1 mg epinephrine and 1 mg sodium bisulfite. Sodium bisulfite is an antioxidant. This solution also contains sodium chloride for adjustment of tonicity, and 10% w/v hydrochloric acid to dissolve epinephrine and to adjust pH to meet USP limits of 2.2 to 5.0. Additionally, the solution also contains sodium citrate and citric acid as buffers for stabilization. The air above the liquid in the individual containers have been displaced by flushing with nitrogen during the filling operation. No antimicrobial preservatives have been added and each vial is intended as a single dose; once the unit is assembled and used, any remaining portion of the solution must be discarded with the entire unit. CLINICAL PHARMACOLOGY The actions of epinephrine resemble the effects of stimulation of adrenergic nerves. To a variable degree, it acts on both alpha and beta receptor sites of sympathetic effector cells. Its most prominent actions are on the beta receptors of the heart, vascular and other smooth muscle. When given by rapid I.V. injection it produces a rapid rise in blood pressure, mainly systolic, direct stimulation of cardiac muscle which increases the strength of ventricular contraction, increases the heart rate, and constricts the arterioles in the skin, mucosa and splanchnic areas of circulation. Epinephrine rela Přečtěte si celý dokument